We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Compass Therapeutics Inc | NASDAQ:CMPX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.86 | 1.85 | 1.87 | 0 | 00:00:00 |
From Jul 2024 to Jan 2025
Details are as follows:
H.C. Wainwright 26th Annual Global Investment Conference Location: New York, NY Date: Monday, September 9, 2024 Time: 11:00am ETWebcast Link: https://journey.ct.events/
Cantor Global Healthcare Conference Location: New York, NYDate: Tuesday, September 17, 2024Time: 8:35am ET Webcast Link: https://wsw.com/webcast/cantor
Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.
About Compass TherapeuticsCompass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.
Investor Contactir@compasstherapeutics.com
Media ContactAnna Gifford, Senior Communications Managermedia@compasstherapeutics.com617-500-8099
1 Year Compass Therapeutics Chart |
1 Month Compass Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
